Evidence map›Paper›PMID 36668834›Full record

ArticleToxins2022

Shear Wave Velocity to Evaluate the Effect of Botulinum Toxin on Post-Stroke Spasticity of the Lower Limb.

Yuki Hasegawa, Masachika Niimi, Takatoshi Hara, Yoshihiro Sakurai, Shigeru Soshi, Jun Udaka, Masahiro Abo

Open access · goldAbstract read
In one paragraph

Article in Toxins, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Yuki HasegawaDepartment of Rehabilitation Medicine, The Jikei University School of Medicine, Tokyo 105-8461, Japan.ORCID 0000-0001-9420-3535
Masachika NiimiDepartment of Rehabilitation Medicine, Nihon University School of Medicine, Tokyo 173-8610, Japan.ORCID 0000-0002-8631-7820
Takatoshi HaraDepartment of Rehabilitation Medicine, The Jikei University School of Medicine, Tokyo 105-8461, Japan.ORCID 0000-0002-4153-168X
Yoshihiro SakuraiDepartment of Rehabilitation Medicine, The Jikei University School of Medicine, Tokyo 105-8461, Japan.
Shigeru SoshiDepartment of Orthopedic Surgery, The Jikei University School of Medicine, Tokyo 105-8461, Japan.
Jun UdakaTetsujikai Medical Corporation Kasuga Clinic, Fukuyama 721-0907, Japan.
Masahiro AboDepartment of Rehabilitation Medicine, The Jikei University School of Medicine, Tokyo 105-8461, Japan.ORCID 0000-0001-6701-4974
Jikei University School of Medicine · JPKishokai Medical Corporation · JPNihon University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: The evaluation of muscles with spasticity using ultrasound elastography has attracted attention recently, and the shear wave velocity (SWV) technique can measure the mechanical properties of tissues objectively and quantitatively. The purpose of this study was to evaluate the effect of using SWV to assess the effect of Botulinum toxin type A (BoNT-A) treatment in adult patients with post-stroke lower limb spasticity. (2) Methods: We assessed the modified Ashworth Scale, the modified Tardieu Scale, and SWV at rest and after stretching before and at 1 month after BoNT-A treatment in 10 adult participants with post-stroke lower limb spasticity. (3) Results: Significant changes in SWV of the ankle joint in maximum dorsiflexion to the extent possible (SWV stretched) were observed after BoNT-A treatment. SWV stretched was positively correlated with joint range of motion. Participants whose joint range of motion did not improve (i.e., gastrocnemius medialis muscle (GCM) extension distance did not change) had significantly more reductions in SWV stretched after BoNT-A treatment. (4) Conclusions: Our results suggest that the SWV measurements may serve as a quantitative assessment to determine the effect of the BoNT-A treatment in adult stroke patients. SWV measurements to assess GCM spasticity should consider the effects of tension, material properties and activation level of muscles. The challenge is to measure SWV with matching limb positions in patients without contractures.

Indexed as

Botulinum Toxins, Type ANeuromuscular AgentsStrokeAdultHumansLower ExtremityMuscle, SkeletalMuscle SpasticityTreatment OutcomeBotulinum Toxins, Type ANeuromuscular Agentsbotulinum toxin type Agastrocnemius medialis musclepost-stroke spasticityshear wave velocityultrasound elastography

Identifiers

PMID36668834
PMCPMC9865964
OpenAlexW4313259523

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.